MIRA Pharmaceuticals, Inc. Discusses Potential of Revolutionary THC Analog Drug, MIRA1a, with The Stock Day Podcast

Stock Information for MIRA Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MIRA Pharmaceuticals Inc.

CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials
C-Bond Systems, Inc. Discusses 2023 Highlights and 2024 Goals with The Stock Day Podcast
US Nuclear Corp. Discusses Real-World Applications of Its Drone Detection Technology with The Stock Day Podcast
Ensysce Biosciences Discusses TAAP and MPAR(R) Applications and OncoZenge Partnership with The Stock Day Podcast
Mushrooms Inc. Discusses Utility Patent Filing For MYCO Thread Applications on The Stock Day Podcast
C-Bond Systems, Inc. Discusses $500,000 Commercial Project with The Stock Day Podcast
AITX CEO, Steve Reinharz, Discusses 2024 Sales Outlook with the Stock Day Podcast
AmpliTech Group, Inc. Discusses 2023 Revenue Projections and 2024 Technology Applications with The Stock Day Podcast

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.